HALB

HALBERD CORP by Halberd Corp. (HALB)

About HALBERD CORP by Halberd Corp. (HALB)

Halberd Corp. is a development stage company, which engages in the research and development of antibodies and devices for the prevention, detection, and treatment of neurodegenerative diseases. It offers patented extracorporeal treatment that is applicable to various blood-borne and neurologic diseases such as PTSD/ CTE (Post Traumatic Stress Disorder/Chronic Traumatic Encephalopathy), Alzheimer's Disease, and Parkinson's Disease. The company was founded by Mark Sven Lundquist and John Christopher Maddox on January 26, 2009 and is headquartered in Jackson Center, PA.

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.01
52 Week Low
$0.00
Market cap
1.2M
Dividend yield
0.00%
Volume
165,051
Avg. volume
408,620
P/E ratio
.00

HALBERD CORP by Halberd Corp. News

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.01
52 Week Low
$0.00
Market cap
1.2M
Dividend yield
0.00%
Volume
165,051
Avg. volume
408,620
P/E ratio
.00